Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;197(4):897-906.
doi: 10.2214/AJR.10.6330.

Evaluation of renal masses with contrast-enhanced ultrasound: initial experience

Affiliations

Evaluation of renal masses with contrast-enhanced ultrasound: initial experience

Scott Gerst et al. AJR Am J Roentgenol. 2011 Oct.

Abstract

Objective: Nearly 25% of solid renal tumors are indolent cancer or benign and can be managed conservatively in selected patients. This prospective study was performed to determine whether preoperative IV microbubble contrast-enhanced ultrasound can be used to differentiate indolent and benign renal tumors from more aggressive clear cell carcinoma.

Subjects and methods: Thirty-four patients with renal tumors underwent preoperative gray-scale, color, power Doppler, and octafluoropropane microbubble IV contrast-enhanced ultrasound. Three blinded radiologists reading in consensus compared rate of contrast wash-in, grade and pattern of enhancement, and contrast washout compared with adjacent parenchyma. Contrast ultrasound findings were compared with surgical histopathologic findings for all patients.

Results: The 34 patients had 23 clear cell carcinomas, three type 1 papillary carcinomas, one chromophobe carcinoma, one clear rare multilocular low-grade malignant tumor, two unclassified lesions, three oncocytomas, and one benign angiomyolipoma. The combination of heterogeneous lesion echotexture and delayed lesion washout had 85% positive predictive value, 43% negative predictive value, 48% sensitivity, and 82% specificity for predicting whether a lesion was conventional clear cell carcinoma or another tumor. Diminished lesion enhancement grade had 75% positive predictive value, 81% negative predictive value, 55% sensitivity, and 91% specificity for non-clear cell histologic features, either benign or low-grade malignant. Combining delayed washout with quantitative lesion peak intensity of at least 20% of kidney peak intensity had 91% positive predictive value, 40% negative predictive value, 63% sensitivity, and 80% specificity in the prediction of clear cell histologic features.

Conclusion: Ultrasound features of gray-scale heterogeneity, lesion washout, grade of contrast enhancement, and quantitative measure of peak intensity may be useful for differentiating clear cell carcinoma and non-clear cell renal tumors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
47-year-old woman with clear cell carcinoma. Postpeak hyperenhancement (delayed washout) was confirmed both visually and at quantitative analysis. A, Color Doppler image shows heterogeneous 3.8-cm right renal mass with marked flow. B, Split-screen ultrasound images from qualitative analysis (left, gray scale; right, contrast enhanced) obtained 16 seconds after contrast injection show heterogeneous lesion enhancement (arrows) of higher grade than that of adjacent renal parenchyma (asterisks). Early phase heterogeneous enhancement became uniform. C, Split-screen qualitative analysis images 19 seconds after injection show closer to uniform lesion enhancement (arrows) and higher-grade enhancement than of adjacent kidney (asterisk).
Fig. 2
Fig. 2
58-year-old woman with metastatic disease consistent with clear cell carcinoma of renal origin. A, Gray-scale ultrasound image shows right renal heterogeneous 5-cm mass (T) projecting within central sinus fat. B, Autotracking contrast quantification mixed-mode image obtained immediately after renal peak shows moderate to marked heterogeneous lesion enhancement (T) compared with adjacent kidney and relative lack of washout. Arrows indicate lesion. C, Time-enhancement curve confirms qualitative visual findings. Tumor (T) data points (white) show higher peak of enhancement with relative lack of washout after renal peak (blue) in corticomedullary phase. ROI = region of interest.
Fig. 3
Fig. 3
54-year-old man with 7.0-cm right renal papillary carcinoma. A, Gray-scale image shows minimally heterogeneous 7-cm mass (calipers). B, Color Doppler image shows lesion (T) has confirmed minimal flow. C, Autotracking contrast quantification mixed-mode imaging shows minimal lesion (T) enhancement compared with adjacent renal parenchyma (K). D, Time-enhancement curve confirms qualitative findings. Lesion (T) data points (white) show minimal enhancement compared with renal parenchymal (K) data points (blue).
Fig. 4
Fig. 4
60-year-old man with 6.8-cm right renal clear cell carcinoma. A, Power Doppler image shows heterogeneous exophytic solid mass (arrow) with confirmed internal flow. B, Qualitative split-screen gray-scale (left) and contrast-enhanced (right) images obtained 16 seconds after contrast injection shows nodular mixed penetrating and peripheral heterogeneous enhancement (arrows) within tumor (T) that is greater than enhancement of kidney (asterisk). C, Split-mode screen qualitative analysis image obtained 33 seconds after contrast injection, after renal peak, shows lesion (T) has continued higher grade of contrast enhancement (arrows) than adjacent rim of normal renal parenchyma (asterisk), constituting lack of lesion washout.

Comment in

References

    1. Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol. 2000;27:124–137. - PubMed
    1. Forman HP, Middleton WD, Melson GL, McClennan BL. Hyperechoic renal cell carcinomas: increase in detection at US. Radiology. 1993;188:431–434. - PubMed
    1. Volpe A, Jewett MA. The role of surveillance for small renal masses. Nat Clin Pract Urol. 2007;4:2–3. - PubMed
    1. Volpe A, Jewett MA. Current role, techniques and outcomes of percutaneous biopsy of renal tumors. Expert Rev Anticancer Ther. 2009;9:773–783. - PubMed
    1. Vasudevan A, Davies RJ, Shannon BA, Cohen RJ. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 2006;97:946–949. - PubMed

Publication types